Patients worldwide benefit every day from our industry-leading multiple sclerosis (MS) products. We have one of the strongest late-stage pipelines in the industry. In the coming years, we're working hard to bring new therapies to market for patients with MS, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), hemophilia and other areas of high, unmet need.
Biogen Idec employs more than 5,000 people worldwide. Our corporate headquarters are located in Weston, Mass.; with research operations in Cambridge, Mass.; international headquarters in Switzerland; and world-class manufacturing facilities in North Carolina. We also have a strong affiliate presence in more than 30 countries and a network of distribution partners in more than 70 additional countries.